Our Q2 2010 report highlighted several significant catalysts that resulted in double-digit stock price changes, details of which can be found in the table on Page 2 of the report.

Our Q3 2010 report includes 12 events expected to take place this quarter, including six FDA Advisory Committees and three PDUFAs. Additionally, we have again included comprehensive calendars for the remainder of 2010 from our sister product, CatalystTracker, of Large Impact catalysts in the drug, device/diagnostic and natural resource areas.

For the full report, please download the PDF version at the top of this page.

For our disclosures, please read the BioMedTracker Research Standards.